Nevertheless, AZD1208 efficiently inhibited PIM kinases, as evaluated by BAD-S112 phosphorylation, at a concentration of 1 μM in the two BL and the two ABC-DLBCL cell lines assessed in our study. Here, BAD is linked to diffuse large B-cell lymphoma.